MJNA CEO takes leave of absence News for 'MJNA' -

MJNA CEO takes leave of absence

News for 'MJNA' - ( Medical Marijuana Inc. Announces that Interim President and CEO, Michael  Llamas, is Taking a Leave of Absence from the Company)


SAN DIEGO, Sept. 17, 2012 /PRNewswire via COMTEX/ -- Medical Marijuana Inc.
(OTC: MJNA), a leading hemp industry innovator, announces today that its Interim
President and CEO, Michael Llamas, is taking a leave of absence effective
immediately. According to the company, Mr. Llamas will be stepping down from his
position in order to focus his attention on personal business matters that are
entirely unrelated to MJNA.

The Company has appointed Ted Caligiuri as the new Interim President and CEO.
Mr. Caligiuri has served on the Board of MJNA since the Company was acquired by
Cannabank and has been instrumental to the overall development of the company,
especially in the area of Hemp-based CBD production.

"We support Michael as he addresses his personal matters and look forward to his
involvement with MJNA upon the successful conclusion of those issues. In the
meantime, the future for MJNA has never looked brighter and we fully expect to
continue executing on our business plan," states Mr. Caligiuri. "With the
successful launch of our CBD line of products, the increased production of our
hemp-based CBD oil and the positive performance of our other portfolio companies
we are confident that MJNA will continue to thrive during this management
transition."

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their integrity
and entrepreneurial spirit. We strive to create awareness within our industry,
develop environmentally friendly, economically sustainable businesses, while
increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that
violate United States Law or the controlled substance act.

For more information, please visit the company's website
at:www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material contains statements
about expected future events and/or financial results that are forward-looking
in nature and subject to risks and uncertainties. Such forward-looking
statements by definition involve risks, uncertainties and other factors, which
may cause the actual results, performance or achievements of Medical Marijuana,
Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been
evaluated by the Food and Drug Administration (FDA). These products and
statements are not intended to diagnose, treat, cure, or prevent any disease.

Corporate Contact:Medical Marijuana, Inc.Toll Free: 888-OTC-MJNA
(888-682-6562) www.medicalmarijuanainc.comwww.facebook.com/mjnainc

Investor Relations Contact:Stuart T. SmithSmallCapVoice.Com, Inc.P.
512-267-2430F. 512-267-2530Email:  ssmith@smallcapvoice.comSkype :
SmallCapVoice.comAIM: SmallCapVoice7

SOURCE Medical Marijuana Inc.



www.prnewswire.com


Copyright (C) 2012 PR Newswire. All rights reserved